Status:

COMPLETED

Insulin Modelling Based on Plasma Glucose Measures Via a Minimally-Invasive Glucose Sensor

Lead Sponsor:

Singapore Institute of Food and Biotechnology Innovation

Collaborating Sponsors:

Institute for Human Development and Potential (IHDP), Singapore

Conditions:

PreDiabetes

Eligibility:

All Genders

21-60 years

Phase:

NA

Brief Summary

The study aims to evaluate insulin as a potential biomarker for prediabetes in Singapore Chinese subjects.

Detailed Description

The prevalence of type 2 diabetes (T2DM) in Singapore is expected to increase from 400,000 to 1,000,000 individuals by 2050, resulting in nearly US$2 billion in economic costs. Pre-diabetes is defined...

Eligibility Criteria

Inclusion

  • Aged 21-60
  • Chinese ethnicity
  • Male or female
  • Adequate fluency in the English language to understand the informed consent process, study instructions and study assessments.
  • Sufficient vision and hearing to complete the study procedures
  • Willing and able to participate and to give written informed consent

Exclusion

  • Diabetes diagnosis based on HbA1c ≥ 6.5%, and fasting plasma glucose ≥ 7.0 mmol/L
  • Past (\<3 months prior to the study) or current major metabolic, endocrine, gastrointestinal or cardiovascular disease
  • Individuals diagnosed with non-alcoholic fatty liver disease
  • Women diagnosed with polycystic ovary syndrome
  • Major surgery in the past 2 months
  • Past (\<1 month prior to the study) or current use of prescription, over the counter or traditional medication that may influence metabolic or gastrointestinal functioning
  • Presence or past history of alcohol or drug addiction
  • Smoking
  • Pregnant or lactating
  • Alcohol intake \>1 units per day
  • Body Mass Index \<18.5 kg/m2 or ≥30 kg/m2
  • Member of the research team or their immediate family members

Key Trial Info

Start Date :

November 6 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 12 2024

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT06119035

Start Date

November 6 2023

End Date

January 12 2024

Last Update

February 2 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Human Development Research Centre, SICS, A*STAR

Singapore, Singapore, 117597